Operating Lease, Right-of-Use Asset in USD of Ventyx Biosciences, Inc. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ventyx Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • Ventyx Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $8,883,000.000, a 10.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Ventyx Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8,883,000 -$1,035,000 -10.4% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $9,151,000 -$1,011,000 -9.9% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $9,413,000 -$1,001,000 -9.6% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $9,669,000 -$1,840,000 -16% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $9,918,000 -$1,928,000 -16.3% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $10,162,000 +$8,831,000 +6.6% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $10,414,000 +$8,978,000 +6.3% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $11,509,000 +$9,972,000 +6.5% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $11,846,000 +$10,217,000 +6.3% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1,331,000 -$402,000 -23.2% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $1,436,000 +$124,000 +9.5% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $1,537,000 +$137,000 +9.8% 31 Dec 2022 10-K 27 Feb 2024
Q3 2022 $1,629,000 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 $1,733,000 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $1,312,000 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $1,400,000 01 Jan 2022 10-K 23 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.